Last updated: October 22, 2025
Sponsor: Vanderbilt University Medical Center
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Progressive Supranuclear Palsy
Treatment
Art Thrapy
Clinical Study ID
NCT06588673
240791
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of progressive supranuclear palsy
Have the cognitive ability to provide informed consent
Exclusion
Exclusion Criteria:
Primary neurological diagnosis other than progressive supranuclear palsy
Cognition too impaired to provide informed consent
Study Design
Total Participants: 10
Treatment Group(s): 1
Primary Treatment: Art Thrapy
Phase:
Study Start date:
January 14, 2025
Estimated Completion Date:
December 02, 2026
Study Description
Connect with a study center
Vanderbilt University Medical Center
Nashville, Tennessee 37232
United StatesSite Not Available
Vanderbilt University Medical Center
Nashville 4644585, Tennessee 4662168 37232
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.